-
Now is the time to ‘up our game’ in using evidence to address health challenges
The COVID-19 pandemic created a once-in-a-generation focus on evidence. We now have the opportunity to systematize the aspects of evidence use that are going well and to address the many gaps.
Alongside the 75th World Health Assembly, Cochrane and the Global Commission...
27 Mai 2022
-
Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals.
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA...
27 Mai 2022
-
26 Mai 2022
-
Pay-for-performance (P4P) is an approach whereby individuals, teams or facilities within the health system are given money or other rewards for meeting service‐related targets, carrying out specific tasks or for meeting specific quality or health outcome thresholds. P4P has been one of the most ideologically charged topics in recent years in...
26 Mai 2022
-
Specifications: Permanent
Salary: circa £45,000 per annum
Location: UK
Application Closing Date: 5 June 2022
The Evidence Production and Methods Directorate in Cochrane is made up of three departments that are responsible for the efficient and timely production of high-quality Cochrane Reviews addressing research questions that are...
24 Mai 2022
-
20 Mai 2022
-
Clinical Trials Day is celebrated on 20 May marking the day in 1747 on which James Lind is believed to have begun the first known controlled trial, comparing different treatments for scurvy which was common among sailors in the British Royal Navy. (Watch a video explaining the trial to see history in the making.)
Learn about Cochrane systematic...
19 Mai 2022
-
11 Mai 2022
-
10 Mai 2022
-
'Interventions to reduce the risk of coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2) infection among workers outside healthcare settings'
What is the aim of this review?
Coronavirus (COVID‐19) is a respiratory infectious disease that has spread globally. People infected with SARS‐CoV‐2 (severe acute respiratory syndrome...
9 Mai 2022
-
9 Mai 2022
-
Specifications: Full Time (Permanent role)
Salary: £85,000 per annum
Location: UK, homebased and remote-working (attendance at meetings will be expected to pursue development and build relations)
Application Closing Date: Monday 6th June 2022, 9am GMT. The recruitment agency will be longlisting applications as soon as they receive...
6 Mai 2022
-
Dear Friends and Colleagues
Due to the continued global impact of COVID-19 (coronavirus) with ongoing reduced/restricted travel from many regions, and the advent of geo-political instability and risks in the European region, we have taken the decision to postpone the Global Evidence Summit (GES 2), due to be hosted in Prague between 2 – 6 October...
4 Mai 2022
-
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, which gives results in less than two hours, simultaneously diagnosing tuberculosis and testing if the bacteria have...
2 Mai 2022
-
27 April 2022
-
25 April 2022
-
Cochrane wants to welcome people, no matter who they are or where they live. The more varied perspectives we have, the better we can provide evidence to help inform health and healthcare decisions.
In October 2021, we launched our listening and learning exercise that aimed to gather data, views and experiences regarding diversity and...
25 April 2022
-
11 April 2022
-
New Cochrane Review: Control interventions in randomised trials for people with a mental health disorder
KEY MESSAGES
Researchers use many different control interventions in randomized trials on treatments for patients with mental health disorders, but there is little consensus on how to report and adequately design these controls. This practice...
8 April 2022
-
Cochrane’s Governing Board is pleased to announce the appointment of Catherine Spencer as Cochrane’s new Chief Executive Officer.
Catherine joins Cochrane from The Seafarers’ Charity where she held the position of CEO.
Prior to her role at The Seafarers’ Charity, Catherine was acting Chief Operating Officer and Director of Communications and...
7 April 2022
Now is the time to ‘up our game’ in using evidence to address health challenges The COVID-19 pandemic created a once-in-a-generation focus on evidence. We now have the opportunity to systematize the aspects of evidence use that are going well and to address the many gaps. Alongside the 75th World Health Assembly, Cochrane and the Global Commission...27 Mai 2022
Readable, clinically-focused, actionable answers to inform point-of-care decision-making for health professionals. Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically-focused entry point to rigorous research from Cochrane Reviews. They are designed to be actionable and to inform point-of-care decision-making. Each CCA...27 Mai 2022
26 Mai 2022
Pay-for-performance (P4P) is an approach whereby individuals, teams or facilities within the health system are given money or other rewards for meeting service‐related targets, carrying out specific tasks or for meeting specific quality or health outcome thresholds. P4P has been one of the most ideologically charged topics in recent years in...26 Mai 2022
Specifications: Permanent
20 Mai 2022
Clinical Trials Day is celebrated on 20 May marking the day in 1747 on which James Lind is believed to have begun the first known controlled trial, comparing different treatments for scurvy which was common among sailors in the British Royal Navy. (Watch a video explaining the trial to see history in the making.) Learn about Cochrane systematic...19 Mai 2022
11 Mai 2022
10 Mai 2022
'Interventions to reduce the risk of coronavirus SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus‐2) infection among workers outside healthcare settings' What is the aim of this review? Coronavirus (COVID‐19) is a respiratory infectious disease that has spread globally. People infected with SARS‐CoV‐2 (severe acute respiratory syndrome...9 Mai 2022
9 Mai 2022
Specifications: Full Time (Permanent role)
Dear Friends and Colleagues Due to the continued global impact of COVID-19 (coronavirus) with ongoing reduced/restricted travel from many regions, and the advent of geo-political instability and risks in the European region, we have taken the decision to postpone the Global Evidence Summit (GES 2), due to be hosted in Prague between 2 – 6 October...4 Mai 2022
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, which gives results in less than two hours, simultaneously diagnosing tuberculosis and testing if the bacteria have...2 Mai 2022
27 April 2022
25 April 2022
Cochrane wants to welcome people, no matter who they are or where they live. The more varied perspectives we have, the better we can provide evidence to help inform health and healthcare decisions.
11 April 2022
New Cochrane Review: Control interventions in randomised trials for people with a mental health disorder KEY MESSAGES Researchers use many different control interventions in randomized trials on treatments for patients with mental health disorders, but there is little consensus on how to report and adequately design these controls. This practice...8 April 2022
Cochrane’s Governing Board is pleased to announce the appointment of Catherine Spencer as Cochrane’s new Chief Executive Officer. Catherine joins Cochrane from The Seafarers’ Charity where she held the position of CEO. Prior to her role at The Seafarers’ Charity, Catherine was acting Chief Operating Officer and Director of Communications and...7 April 2022